Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-23T08:29:01.652Z Has data issue: false hasContentIssue false
  • English
  • Français

Establishing Surveillance for Carbapenem-Resistant Enterobacteriaceae in Minnesota, 2012

Published online by Cambridge University Press:  10 May 2016

Kristin M. Shaw ,
Jane E. Harper ,
Paula Snippes Vagnone  and
Ruth Lynfield
Kristin M. Shaw*
Affiliation:
Minnesota Department of Health, Saint Paul, Minnesota
Jane E. Harper
Affiliation:
Minnesota Department of Health, Saint Paul, Minnesota
Paula Snippes Vagnone
Affiliation:
Minnesota Department of Health, Saint Paul, Minnesota
Ruth Lynfield
Affiliation:
Minnesota Department of Health, Saint Paul, Minnesota
*
625 Robert Street North, St. Paul, MN 55155 ([email protected])
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 4: Special Topic Issue: Carbapenem-Resistant Enterobacteriaceae and Multidrug-Resistant Organisms , April 2014 , pp. 451 - 453
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2014

References

1. Ben-David, D, Kordevani, R, Keller, N, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012;18(1):54–60.Google Scholar
2. Patel, G, Huprikar, S, Factor, SH, Jenkins, SG, Calfee, DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29(12):1099–1106.CrossRefGoogle ScholarPubMed
3. Schwaber, MJ, Klarfeld-Lidji, S, Navon-Venezia, S, Schwartz, D, Leavitt, A, Carmeli, Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52(3):1028–1033.Google Scholar
4. Munoz-Price, LS, Hayden, MK, Lolans, K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010;31(4):341–347.Google Scholar
5. Won, SY, Munoz-Price, LS, Lolans, K, et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011;53(6):532–540.CrossRefGoogle ScholarPubMed
6. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Wayne, PA: CLSI, 2012. CLSI document: M100-S22.Google Scholar
7. Kochar, S, Sheard, T, Sharma, R, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae . Infect Control Hosp Epidemiol 2009;30(5):447–452.CrossRefGoogle ScholarPubMed
8. Marquez, P, Terashita, D, Dassey, D, Mascola, L. Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County. Infect Control Hosp Epidemiol 2013;34(2):144–150.CrossRefGoogle ScholarPubMed
9. Centers for Disease Control and Prevention. Guidance for Control of Carbapenem-ResistantEnterobacteriaceae (CRE): 2012 CRE Toolkit. http://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf. 2012. Accessed August 19, 2013.Google Scholar
10. Schwaber, MJ, Lev, B, Israeli, A, et al. Containment of a country-wide outbreak of carbapenem-reisstant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52(7):848–855.CrossRefGoogle Scholar